Annals of Oncology · 2019 · 190 citations · 32 references
MedicineMolecular MedicineOncologyMolecular DiagnosticsMolecular OncologyTumor ProgressionCancer BiomarkersCancer Molecular DiagnosticsCirculating Tumor CellsCirculating Tumor Dna AnalysisMalignant NeoplasmsRecurrence MonitoringCancer Recurrence MonitoringCirculating Cell-free Dna AnalysisCirculating Tumor BiomarkersCirculating Tumor Cell MonitoringCirculating Tumor Dna DetectionCirculating Tumor Dna TestingCirculating Tumor MarkersMelanoma Biomarkers
32
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14